{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:49:03Z","timestamp":1771530543096,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1093\/rheumatology\/ken484","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T01:08:06Z","timestamp":1243818486000},"page":"iii54-iii57","source":"Crossref","is-referenced-by-count":10,"title":["Vasculopathy and pulmonary arterial hypertension"],"prefix":"10.1093","volume":"48","author":[{"given":"L.","family":"Guillevin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,5,28]]},"reference":[{"key":"key\n\t\t\t\t20170703123123_B1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.nrl.0000252942.14928.17","article-title":"Vasculitic neuropathies: an update","volume":"13","author":"Gorson","year":"2007","journal-title":"Neurologist"},{"key":"key\n\t\t\t\t20170703123123_B2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B3","first-page":"114","article-title":"Clinical classification of vasculitis","volume":"16","author":"Sunderkotter","year":"2006","journal-title":"Eur J Dermatol"},{"key":"key\n\t\t\t\t20170703123123_B4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.md.0000216817.35937.70","article-title":"Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients","volume":"85","author":"Ramos-Casals","year":"2006","journal-title":"Medicine"},{"key":"key\n\t\t\t\t20170703123123_B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1780390103","article-title":"Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium","volume":"39","author":"Belmont","year":"1996","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B6","first-page":"985","article-title":"Pulmonary hypertension associated with systemic lupus erythematosus","volume":"188","author":"Haas","year":"2004","journal-title":"Bull Acad Natl Med"},{"key":"key\n\t\t\t\t20170703123123_B7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10067-006-0206-5","article-title":"Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension","volume":"25","author":"Chung","year":"2006","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170703123123_B8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170703123123_B9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.autrev.2006.11.001","article-title":"Mycophenylate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?","volume":"6","author":"Iaccarino","year":"2007","journal-title":"Autoimmun Rev"},{"key":"key\n\t\t\t\t20170703123123_B10","first-page":"392","article-title":"Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension associated with connective tissue disease","volume":"65","author":"Guillevin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170703123123_B11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clindermatol.2006.07.005","article-title":"Sj\u00f6gren's syndrome in dermatology","volume":"24","author":"Fox","year":"2006","journal-title":"Clin Dermatol"},{"key":"key\n\t\t\t\t20170703123123_B12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170703123123_B13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncprheum0165","article-title":"The management of Sj\u00f6gren's syndrome","volume":"2","author":"Mavragani","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"key\n\t\t\t\t20170703123123_B14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3949\/ccjm.64.10.523","article-title":"The uncertain role of immunosuppressive agents in Sj\u00f6gren's syndrome","volume":"64","author":"Linardaki","year":"1997","journal-title":"Cleve Clin J Med"},{"key":"key\n\t\t\t\t20170703123123_B15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/03009740600765032","article-title":"Clinical features and endothelin receptor antagonist in primary Sj\u00f6gren's syndrome with pulmonary arterial hypertension","volume":"35","author":"Chen","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"key\n\t\t\t\t20170703123123_B16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u00f6gren's syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170703123123_B17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","article-title":"Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides","volume":"2","author":"Kallenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"key\n\t\t\t\t20170703123123_B18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780390112","article-title":"The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources","volume":"39","author":"Cotch","year":"1996","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B19","first-page":"60","article-title":"Treatment of ANCA-associated systemic vasculitis","volume":"64","author":"Belmont","year":"2006","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"key\n\t\t\t\t20170703123123_B20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncprheum0139","article-title":"Therapeutics of Wegener's granulomatosis","volume":"2","author":"Wung","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"key\n\t\t\t\t20170703123123_B21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-2006-939518","article-title":"Churg-Strauss syndrome","volume":"27","author":"Keogh","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170703123123_B22","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.1780351113","article-title":"The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate","volume":"35","author":"Hoffman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/art.20234","article-title":"Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis","volume":"51","author":"Slot","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic antibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170703123123_B25","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/rheumatology\/36.12.1290","article-title":"Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides","volume":"36","author":"Gayraud","year":"1997","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t20170703123123_B27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/90.6.401","article-title":"Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis","volume":"90","author":"Adu","year":"1997","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t20170703123123_B28","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B29","first-page":"S10","article-title":"Rapidly progressive glomerulonephritis: current and evolving treatment strategies","volume":"17","author":"Little","year":"2004","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t20170703123123_B30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"Wegener's Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170703123123_B31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170703123123_B32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/ard.61.6.559","article-title":"Safety and efficacy of TNF alpha blockade in relapsing vasculitis","volume":"61","author":"Booth","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170703123123_B33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170703123123_B34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2006.056630","article-title":"Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature","volume":"66","author":"Daikeler","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/48\/suppl_3\/iii54\/18096382\/ken484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T20:58:19Z","timestamp":1503521899000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/ken484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":34,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2009,5,28]]},"published-print":{"date-parts":[[2006,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/ken484","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}